Objective To investigate the effect of multimodal analgesia on quality of recovery in patients with hepatocellular carcinoma (HCC) undergoing trans-abdominal partial hepatectomy. Methods A total of 110 patients with HCC underwent patial hepatectomy, 84 males and 26 females, aged 18-75 years, BMI 18.0-25.0 kg/m2, ASA physical status Ⅱ or Ⅲ, were randomized into a multimodal analgesia group (group M) and a control group (group C), 55 patients in each group. In group M, all patients were injected 40 mg parecoxib sodium intravenously 30 minutes before anesthesia induction and received ultrasound-guided transversus abdominis plane block (TAPB) using 0.375% ropivacaine 20 ml at the end of the surgery. Postoperatively, a dose of 40 mg parecoxib sodium was intravenously injected twice daily for three days. The patients in the control group didnt receive the treatment mentioned above. Patients controlled intravenous analgesia (PCIA) and intravenous administration of oxycodone 5 mg after surgery were used in all patients. The postoperative NRS scores at 2, 6, 12, 24, 48, and 72 hours, first time of off-bed activity and intestinal exhaust, number of rescue analgesia were recorded. The QoR-40 score scale was used to assess the recovery quality of patients respectively on day 1 preoperatively, and day 1, 3, 30 postoperatively. The adverse reactions of postoperative nausea and vomiting, itching, respiratory depression, and hypotension were recorded. Results Compared with group C, NRS scores 2, 6, 12, 24, 48, and 72 hours after the surgery were lower in group M (P < 0.05). A lower risk of rescue analgesia was also reported in patients in group M (P < 0.05). The first time of off-bed activity, intestinal exhaust and the incidence of nausea and vomiting were significantly reduced (P < 0.05). QoR-40 scores were significantly lower in M group than in group C on the 1st and 3rd postoperative days (P < 0.05). Conclusion The multimodal analgesia which uses non-steroidal anti-inflammatory drugs (NSAIDs) preoperatively for prophylactic analgesia, postoperative TAPB and NSAIDs for continuous analgesia treatment can accelerate the rehabilitation process of patients and improve the postoperative recovery quality of patients undergoing trans-abdominal partial hepatectomy. |